Information Technology - News & Updates

Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment of a second NVIDIA DGX SuperPOD, strengthening its efforts to…
Read More...

Excalipoint Therapeutics and DP Technology have announced a strategic collaboration to develop a new artificial intelligence (AI) platform designed to speed up the discovery of T-cell…
Read More...

Evogene has partnered with Tel Aviv University’s Blavatnik Center for Drug Discovery to establish a joint initiative aimed at accelerating small-molecule drug discovery programmes…
Read More...

Certara, Inc. has announced a collaboration with NVIDIA aimed at expanding the use of agentic artificial intelligence across drug discovery and development workflows. The partnership…
Read More...

Bayer has entered into a strategic drug discovery collaboration with Iambic Therapeutics to accelerate the development of new small-molecule medicines using artificial intelligence. The…
Read More...

XtalPi has entered into a strategic collaboration with a leading international biopharmaceutical company to develop a next-generation small-molecule therapy targeting a complex G…
Read More...

Alnylam Pharmaceuticals and Inceptive Nucleics have entered into a strategic collaboration valued at up to $2 billion aimed at accelerating the development of next-generation RNA-based…
Read More...

Insilico Medicine and Human Life Foundation Models, Inc. (HLFM) have entered into a multi-million-dollar collaboration to develop what the companies describe as the biotechnology…
Read More...

Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery for biotechnology companies through a success-based artificial…
Read More...

QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...

Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence agents designed to support biopharmaceutical decision-making and…
Read More...

MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with Google Cloud aimed at transforming the pharmaceutical giant into a fully…
Read More...

Boehringer Ingelheim has announced a major expansion of its global Computational Innovation network with the launch of a new artificial intelligence (AI) and machine learning (ML)…
Read More...

Viz.ai has announced a strategic partnership with Alnylam Pharmaceuticals aimed at improving the early detection and diagnosis of cardiac amyloidosis, a serious and often underdiagnosed…
Read More...

Roche has announced a major expansion of its global artificial intelligence (AI) infrastructure, unveiling a large-scale “AI factory” powered by next-generation accelerated computing…
Read More...

Merck & Co., Inc., known as MSD outside the United States and Canada, has entered into a major research and development agreement with Mayo Clinic to apply artificial intelligence…
Read More...

Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical System Holdings have announced a multi-project collaboration aimed at…
Read More...

Takeda has entered a multi-year collaboration with clinical-stage biotechnology company Iambic aimed at accelerating the development of new medicines using artificial…
Read More...

Bristol Myers Squibb (BMS) has entered into a strategic collaboration with Microsoft to accelerate the early detection of lung cancer by integrating advanced artificial intelligence…
Read More...

AstraZeneca has acquired Modella AI, a life sciences–focused artificial intelligence company, in a move that deepens the companies’ existing collaboration and strengthens AstraZeneca’s…
Read More...